Shukra Pharmaceuticals allots warrants
Shukra Pharmaceuticals (SHUKRAPHAR) said it has allotted warrants. The company is valued at about ₹3,191 crore.
What happened
Shukra Pharmaceuticals (SHUKRAPHAR) told the exchanges on 6 October 2026 at 06:42 PM that it has allotted warrants.
Company snapshot
Shukra Pharmaceuticals is a small-cap company, with a market value of about ₹3,191 crore.
The stock last traded at ₹72.58, against a 52-week range of ₹40.06–₹75.4 (3.7% below the high).
Before this filing the shares had moved +35.7% over the month. Average daily turnover over the last 20 sessions was about ₹41.53 crore.
Promoters held 51.15% at the end of Q2 FY27, up 0.19% points from the previous quarter. Foreign institutions owned 0.00% and domestic institutions 0.11%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 5 | 1 | 0.02 |
| Q2 FY26 | 6 | 2.4 | 0.05 |
| Q3 FY26 | 39 | 20.4 | 0.47 |
| Q4 FY26 | 6 | -1.7 | -0.04 |
| Q1 FY27 | 24 | 15 | 0.34 |
What history shows
BCEIE has no earlier fund raising filing from this company on record since May 2026.
Market-wide, 1,501 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.